Sysmex (OTCMKTS:SSMXY) Trading 5.9% Higher – Time to Buy?

Sysmex Corporation ADR (OTCMKTS:SSMXY)’s stock price shot up 5.9% on Monday . The company traded as high as $9.82 and last traded at $9.82. 5,246 shares were traded during trading, a decline of 97% from the average session volume of 155,414 shares. The stock had previously closed at $9.27.

Analyst Ratings Changes

Separately, The Goldman Sachs Group raised shares of Sysmex from a “hold” rating to a “buy” rating in a research note on Thursday, October 9th. One equities research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy”.

Sysmex Stock Performance

The business’s fifty day moving average is $10.69 and its two-hundred day moving average is $13.50. The stock has a market capitalization of $6.11 billion, a PE ratio of 19.40 and a beta of 1.17. The company has a quick ratio of 2.49, a current ratio of 3.34 and a debt-to-equity ratio of 0.11.

Sysmex (OTCMKTS:SSMXY) last posted its quarterly earnings data on Wednesday, November 5th. The company reported $0.16 EPS for the quarter, hitting the consensus estimate of $0.16. Sysmex had a net margin of 9.32% and a return on equity of 9.86%. The company had revenue of $826.60 million during the quarter, compared to analyst estimates of $880.80 million. As a group, research analysts anticipate that Sysmex Corporation ADR will post 0.57 EPS for the current fiscal year.

Sysmex Company Profile

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.